Full-Time

Staff NGS Application Manager

Posted on 7/26/2024

Ultima Genomics

Ultima Genomics

201-500 employees

High-throughput genomic sequencing services

Biotechnology
Healthcare

Compensation Overview

$135k - $170kAnnually

+ Bonus + Equity + Benefits

Senior

Fremont, CA, USA

Ability to travel domestically and internationally up to 15%.

Category
Computational Biology
Genomics
Biology & Biotech
Requirements
  • PhD or equivalent advanced degree in computational biology, molecular biology, or related field is required. Minimum of 5+ years in R&D roles, excluding PhD training
  • Deep understanding of and hands-on experience with genomic technologies, sequencing workflows, and their applications
  • Outstanding leadership skills with a demonstrated ability to work effectively in cross-functional teams, preferably experience in multi-disciplinary R&D teams and collaboration with commercial and sales functions. Excellent communication and presentation abilities are essential
  • A hands-on, proactive approach with a high-energy and positive demeanor that drives results
  • Ability to travel domestically and internationally up to 15%
Responsibilities
  • Coordinate seamlessly with R&D teams to drive the development of new NGS applications. Work closely with manufacturing, quality, and support teams to address product issues and ensure high customer satisfaction
  • Act as the primary interface to ensure alignment between technical advancements and commercial strategies
  • Take full ownership of execution from inception to delivery, ensuring that product goals are met and results are effectively communicated to stakeholders and customers
  • Regularly engage with the commercial team and customers to understand market needs, identify opportunities, assess competitive landscapes, and contribute to strategic decision-making
  • Work with marketing team to develop compelling application notes and application collateral that showcase the unique features and benefits of Ultima’s NGS applications

Ultima Genomics improves human health through advanced genomic sequencing technologies, processing large amounts of genetic data to provide insights into biology and diseases. Its unique sequencing architecture allows for extensive data collection, detection of small genetic variations, and routine testing for early disease detection. This capability gives clients, including researchers and healthcare providers, access to high-quality genomic information. The company's goal is to continuously innovate and expand its services to enable significant advancements in understanding and treating diseases.

Company Stage

Late Stage VC

Total Funding

$587.7M

Headquarters

Newark, New Jersey

Founded

2016

Growth & Insights
Headcount

6 month growth

1%

1 year growth

0%

2 year growth

-7%
Simplify Jobs

Simplify's Take

What believers are saying

  • Partnerships with Labcorp and Hartwig enhance cancer diagnostics and treatment.
  • Experienced leadership additions drive operational excellence and commercial adoption.
  • UG 100's cost-effectiveness democratizes access to genomic data.

What critics are saying

  • Competition from Illumina and BGI may impact market share.
  • Rapid technological advancements could render current technologies obsolete.
  • High development costs may strain financial resources if growth lags.

What makes Ultima Genomics unique

  • Ultima Genomics offers ultra-high throughput sequencing with the UG 100 system.
  • Their open silicon wafer substrate reduces sequencing costs significantly.
  • The UG 100 system enables the era of the $100 genome.

Help us improve and share your feedback! Did you find this helpful?

INACTIVE